Polish Ministry of Science and Higher Education together with Czech Ministry of Education, Youth and Sport announced the call for research internship proposals within The Executive Program with Czech Republic 2016-2017....
Read more
The Czech Republic biotechnology sector undergoes substantial changes, similarly as in other countries of CEE region. In an interview with Michal Schmoranz from the Technology transfer office of the Biology Centre of the Czech Academy of Sciences, he describes how the biotechnology field is financed ...
Read more
The Czech Republic biotechnology sector is still in the middle of development process. However, it possesses a strong potential to become one of the leaders in the central European region. One of the well-established Czech biotech companies is Bio Agens Research and Development – BARD Ltd. offering m...
Read more
Concerning central Europe, the Czech Republic is one of the leading countries in biotechnology development with strong research institutes, attractive business environment and proper government and European Union support. It confirms that nations from this part of Europe are becoming equal partners f...
Read more
“Union gives strength.”- a tagline of ‘The Bundle of Sticks’, one of the fables written in the 6th century B.C. by Æsop, seems to be never phased out. It is current even in the biotechnology sector where small and medium companies by cooperation with academic institutes, major professional societies,...
Read more
At the end of January the Czech Senate almost unanimously approved the legal use and sale of cannabis for medical purposes. Subsequently, the bill was signed by a former Czech Republic President Vaclav Klaus. The medical marijuana is available for people suffering from such illnesses as cancer, Parki...
Read more
Leukaemia is a sort of the blood or bone marrow cancer. The main result of this serious disease is an abnormal increment in the number of immature white blood cells (blasts). There are two principal types of leukaemia; in case of the acute one the abundance of the blasts inhibits the formation of the...
Read more
Czech Republic biotech and pharma industry is one of the most important in Central Europe. Nevertheless, for successful competition with the US and Western Europe companies our regional bio-business needs to establish a platform of cooperation, which will unite companies, represent industry needs in...
Read more
Vaclav Horejsi, director of the Institute of Molecular Genetics of the Czech Academy of Sciences announced on the 1. February 2012 that The Czech Education Ministry approved the foundation of the Biotechnology and Biomedicine Centre (Biocev)....
Read more
On the 24th of October in 2012, Marek Pokorny, group leader of Nanotechnology Device Development Group in Contipro, introduced new self-patented device, which will be used in the nanofiber production....
Read more
2nd edition of Pharma Law Convention organized in partnership with The Association of Innovative Pharmaceutical Industry is held in Prague, Czech Republic on 13-14 of March 2013. Its mission is to bring pharmaceutical industry of Central and Eastern Europe together with experts from European regulat...
Read more
Nanotech is The World’s Largest Nanotechnology Exhibition and Conference, which is held every year in Japan – the global leader in the field of nanotechnology. On February 15th - 17th, Czech Republic participated with the 10 representative firms having their own national stand for the first time in t...
Read more
Penta Investments, the Central European investment group, has signed an agreement to sell 100% stake in Alpha medical a.s. and Alpha medical Polska Sp. z o.o. to Mid Europa Partners. The transaction includes the whole Alpha Medical group and its assets in the Czech Republic, Slovakia and Poland. Alph...
Read more
BIOCEV is a joint project of six institutes of the Academy of Sciences of the Czech Republic and two faculties of Charles University in Prague....
Read more
The CONTIPRO company was created in 1990 by Vladimír Velebnýand Petr Pinkas. Its name is a composite of “connective tissue products”, which are widely used in the pharmaceutical and cosmetic industries. The companyhas been involved in R&D and biotechnological production of active ingredients for the ...
Read more
Life Sciences Employers are becoming more militant in the battle for talents. It is not only about sourcing the right professionals from the market but most of all creating the work environment to attract and retain them....
Read more
The simplest definition of Commercialization says it is the process or cycle of introducing a new product or production method into the market. Usually launch of the new product is the final stage of its development. It is the most risky part of this process, the one where the most money will have...
Read more
HAYS Czech Republic, leading global experts in qualified in professional and skilled recruitment, joints to BioForum 2012 (www.cebioforum.com) event, held in Brno, Czech Republic May 23-24th, 2012 and organizes a career day oriented on pharmaceutical and biotech market....
Read more
For already 11 years, the BioForum trade fair (www.cebioforum.com) has been attracting to Łódź, the centre of Poland, a number of biotech sector representatives. Attendees are coming not only from Poland and other Central European countries, but also from other countries from all over the world, whe...
Read more